Position in HRMY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,109,813
-$93,019 QoQ
Shares Held
30,481
-29.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#139
of 328 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Partners holds $329,375,186 across 6 Biotechnology names. HRMY ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
2,773,568 | $217,087,166 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
718,574 | $58,614,080 | |
| 3 | INVA |
Innoviva, Inc.
|
1,927,959 | $43,783,948 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
153,446 | $8,780,179 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
30,481 | $1,109,813 | |
| 6 | 1,658,936 | $0 |
All Filings in HRMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,109,813 | 30,481 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,202,832 | 42,943 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $26,528,645 | 708,943 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $20,778,915 | 753,952 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $19,133,640 | 605,495 | Shares | Defined | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||